HMGCR and posterior cortical atrophy: Subsequently, Mendelian randomization analysis revealed that HMGCR inhibition and PCSK9 inhibition were associated with a reduced risk of PCa, suggesting that HMGCR inhibition may exert its protective effect against PCa through lipid-lowering mechanisms.